Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Effort required in eligibility screening for clinical trials.

Penberthy LT, Dahman BA, Petkov VI, DeShazo JP.

J Oncol Pract. 2012 Nov;8(6):365-70. doi: 10.1200/JOP.2012.000646.

2.

Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.

Ni Y, Wright J, Perentesis J, Lingren T, Deleger L, Kaiser M, Kohane I, Solti I.

BMC Med Inform Decis Mak. 2015 Apr 14;15:28. doi: 10.1186/s12911-015-0149-3.

3.

Supporting patient screening to identify suitable clinical trials.

Bucur A, Van Leeuwen J, Chen NZ, Claerhout B, De Schepper K, Perez-Rey D, Alonso-Calvo R, Pugliano L, Saini K.

Stud Health Technol Inform. 2014;205:823-7.

PMID:
25160302
4.

Automated matching software for clinical trials eligibility: measuring efficiency and flexibility.

Penberthy L, Brown R, Puma F, Dahman B.

Contemp Clin Trials. 2010 May;31(3):207-17. doi: 10.1016/j.cct.2010.03.005.

5.
6.
7.

Validity versus generalizability in clinical trial design and conduct.

Hennekens CH, Buring JE.

J Card Fail. 1998 Sep;4(3):239-41. No abstract available.

PMID:
9754597
8.

Textual inference for eligibility criteria resolution in clinical trials.

Shivade C, Hebert C, Lopetegui M, de Marneffe MC, Fosler-Lussier E, Lai AM.

J Biomed Inform. 2015 Dec;58 Suppl:S211-8. doi: 10.1016/j.jbi.2015.09.008.

9.

Analysis of eligibility criteria from ClinicalTrials.gov.

Doods J, Dugas M, Fritz F.

Stud Health Technol Inform. 2014;205:853-7.

PMID:
25160308
10.

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.

12.

Computer-based screening of patients with HIV/AIDS for clinical-trial eligibility.

Carlson RW, Tu SW, Lane NM, Lai TL, Kemper CA, Musen MA, Shortliffe EH.

Online J Curr Clin Trials. 1995 Mar 28;Doc No 179:[3347 words; 32 paragraphs].

PMID:
7719564
13.

Consecutive screening and enrollment in clinical trials: the way to representative patient samples?

Bjørn M, Brendstrup C, Karlsen S, Carlsen JE.

J Card Fail. 1998 Sep;4(3):225-30; discussion 231.

PMID:
9754593
14.

Consecutive screening and enrollment in clinical trials.

Julian D.

J Card Fail. 1998 Sep;4(3):233. No abstract available.

PMID:
9754594
15.

Clinical trial recruitment in rural South Carolina: a comparison of investigators' perceptions and potential participant eligibility.

Bergeron CD, Foster C, Friedman DB, Tanner A, Kim SH.

Rural Remote Health. 2013 Oct-Dec;13(4):2567.

16.

Modeling SSI financial eligibility and simulating the effect of policy options.

Davies PS, Huynh M, Newcomb C, O'Leary P, Rupp K, Sears J.

Soc Secur Bull. 2001-2002;64(2):16-45. Erratum in: Soc Secur Bull. 2001-2002;64(4):following table of contents.

PMID:
12428508
17.

Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.

Holmes DR, Major J, Lyonga DE, Alleyne RS, Clayton SM.

Am J Surg. 2012 Apr;203(4):415-22. doi: 10.1016/j.amjsurg.2011.02.005.

PMID:
21996347
18.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.

19.
20.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

Items per page

Supplemental Content

Support Center